| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8722703 | HPB | 2018 | 7 Pages |
Abstract
Adding CA19-9 response after induction chemotherapy seems useful in determining which patients with RECIST non-progressive LAPC should undergo exploratory surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Eran van Veldhuisen, Jantien A. Vogel, Sjors Klompmaker, Olivier R. Busch, Hanneke W.M. van Laarhoven, Krijn P. van Lienden, Johanna W. Wilmink, Hendrik A. Marsman, Marc G. Besselink,